Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 106, 104689
Abstract
No abstract availableKeywords
Funding Information
- Academia Sinica (107-0210-01-19-04)
- Ministry of Science and Technology, Taiwan (106-0210-01-15-02)
- Ministry of Science and Technology, Taiwan (107-0210-01-19-01)
- Ministry of Science and Technology, Taiwan (105-2314-B-002-077)
- Ministry of Science and Technology, Taiwan (MOST 106-2314-B-002-021-MY2)
This publication has 40 references indexed in Scilit:
- Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and ImagingPLOS ONE, 2013
- Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristineCancer Chemotherapy and Pharmacology, 2012
- Dynein mediates the localization and activation of mTOR in normal and human cytomegalovirus-infected cellsGenes & Development, 2012
- Challenges in Development of Targeted Liposomal TherapeuticsThe AAPS Journal, 2012
- The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 2011
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1Science, 2011
- Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenograftsAnti-Cancer Drugs, 2008
- Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal ModelsCancer Research, 2006
- Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-upGynecologic Oncology, 2006
- Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2005